Puma Biotechnology Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Puma Biotech (PBYI) Tops Q2 EPS, Revenues Miss
August 5, 2021 5:51 PM EDTPuma Biotech (NASDAQ: PBYI) reported Q2 EPS of $0.32, $0.34 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $48.9 million versus the consensus estimate of $51.6 million.
Net cash used in operating activities for the second quarter of 2021 was $0.1 million, compared to... More
